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High fat diet impacts lipid metabolism by altering the transportation, oxidation, and 
storage of fatty acids. Lipoprotein lipase (LPL) plays a critical role in lipid metabolism by 
catalyzing triglyceride hydrolysis and lipoprotein uptake in multiple tissues. A previous 
study reported that miR-29b negatively regulated LPL expression in mammary epithelial 
cells transfected with miR-29b mimics. The present study investigated changes in LPL 
expression and epigenetic mechanisms by the miR-29 family in different tissues in mice 
fed a high fat diet. Five-week old male CBA mice were fed with either a control diet (Con 
group, 10% kcal from fat) or a high fat diet (HF group, 45% kcal from fat) ad libitum for 
11 weeks. The results showed that LPL mRNA was increased in adipose, muscle and 
colon in response to high fat diet. However, LPL mRNA expression decreased in the 
liver by high fat diet as well as hepatic lipase (HL). The results also showed the highest 
expression level of LPL mRNA in adipose tissue, followed by muscle, colon, and liver. 
Meanwhile, high fat diet reduced the expression of miR-29a/b, predicted suppressors of 
LPL from miR-29 family, in adipose tissue. Genomic analysis predicted several potential 
transcription factors of miR-29 family members that suppress the expression of miR-
29s. At mRNA level, some of these transcription factors, c-Myc and EZH2, were 
significantly activated in response to HF diet. The present results indicated that the LPL 
expression could be activated by high fat diet in multiple tissues and the induction of 
LPL is post-transcriptionally regulated by miR-29a/b. Furthermore, the transcription of 
miR-29 in mice adipose was regulated by certain transcriptional factors. Overall, LPL 
mRNA altered in multiple tissues in response to high fat diet and is potentially regulated 
through transcription factors and microRNAs. 
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Chapter 1： Introduction 
Inadequate or excessive nutritional intake and unhealthy dietary patterns impact the 
normal metabolic function in negative ways, while long term exposure to high fat diet 
causes nutrient overload and leads to metabolic disorders including dyslipidemia, type 2 
diabetes, hypertension, cardiovascular, obesity and other chronic diseases.  
The process of the breakdown of triacylglycerols (TAGs) from diet into glycerol and 
fatty acids (FAs) is called lipolysis, which is catalyzed by lipases [1]. The expression of 
genes encoding lipases can be post-transcriptionally regulated by microRNAs [2]. 
Lipoprotein lipase (LPL), a member of lipases, could be partly matched with miR-29a/b, 
members of miR-29 family. Many studies have reported the importance of the miR-29 
family in cell proliferation, differentiation, apoptosis, and migration [3-6]. However, 
results of experiments conducted in vitro showed the negative regulatory effect of miR-
29a/b on LPL, indicating miR-29a/b might be important in lipid metabolic regulation [7, 
8]. However, the regulatory effects of miR-29a/b on LPL in response to dietary factors, 
like HF diet, in vivo are still poorly understood. Therefore, the responses of miR-29a/b to 
HF diet and the relationship between miR-29a/b and LPL were explored in this study. 
 In this study, miR-29 showed alternative responses to control and HF diet. The 
mechanisms regulating expression of miR-29 in response to dietary factors in mice are 
thus of interest. Based on the existing data, c-Myc was shown to contribute to 
widespread microRNA repression including miR-29 [9]. Although the mechanisms by 
which c-Myc and EZH2 represses miR-29 transcription have been extensively studied in 
vitro [10], less is known about how long-term HF diet affects miR-29 transcription with 
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the mediation of c-Myc and EZH2 in mice. In this study, we explored the role of c-Myc 




Chapter 2： Literature Review 
High fat diet and Lipid metabolism disorder 
High fat (HF) diets alter the expression of genes involved in lipid metabolism and 
cause the increasing risk of insulin resistance, obesity, metabolic syndrome, 
dyslipidemia, and other metabolic disorders. Thus, it is critical to understand the 
regulatory mechanisms by which HF diet intervenes lipid metabolism and ultimately 
causes these chronic diseases. Epigenetic regulation is one of the regulatory 
mechanisms for lipid metabolism impacted by HF diet. It was reported that HF diet 
induced gene expression involved in lipolysis and fatty acid catabolism, such as LPL, 
Cpt1, Pparα, and Ehhadh, in different organs [11-13]. Meanwhile, genes involved in 
fatty acid synthesis were regulated by HF diet in main organs, such as acetyl CoA 
carboxylase (ACC), fatty acid synthesis (FAS), stearoyl coenzyme A desaturase 1 
(Scd1), stearoyl coenzyme A desaturase 2 (Scd2), and Srebp1 [14-17]. There is no 
consistent conclusion about the impact of HF diet in lipid metabolism because, in some 
studies, the effect of HF diet is associated with the composition of fat in diet. In mice fed 
with HF diet (42% calories from fat) contained either saturated fat (71% 16:0 in total 
FAs) or n-3 fish oil (15% 16:0, 16% 20:9 in total FAs) for 12 weeks, HF diets enriched in 
fish oil decreased arterial LPL levels and limited LPL expression, but saturated fat diets 
increased LPL expression compared to control group[18, 19], indicating that the type 
and the portion of fats in diet may be a key factor affecting the metabolic response to 
HF diet. 
Lipid metabolism is defined as physiological processes in the anabolism and 
catabolism of lipids. HF exposure for a period can program the process of lipid 
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metabolism, including synthesis and degradation of lipids in organs and cells. Mice fed 
with a long-term HF diet had problems in lipolysis or lipogenesis. For instance, induction 
of a transcription factor Pparα by HF diet enriched in fish oil can enhance fatty acid 
oxidation in mice muscle, which directed fat into oxidation rather than storage in muscle 
[20]. The level of Pgc1α, the cofactor of Pparα, was also higher in mice fed long-term 
HF diet [20, 21]. Additionally, HF diet can program FA synthesis in tissue-specific 
manners. ACC and Fas are critical enzymes in FA synthesis. The expression of these 
genes was significantly increased in adipose tissues but decreased in liver from HF-fed 
mice[14, 16, 17]. The dysregulation of lipolysis and lipogenesis can cause problems in 
lipid metabolism in main organs.  
Organisms store the FFAs in adipose tissue in the form of triacylglycerols (TAGs). 
Overloaded fats from diet can lead to greater FFA storage and increase adipose mass 
[22]. Many studies showed that genes involved in FA synthesis and lipid uptake were 
significantly increased in the adipose tissue from HF-fed mice. In the adipose tissue, the 
expression of PPARs, including PPAR-α and PPAR-γ, increased in response to HF-diet 
[13, 14, 20, 21]. Following study illustrated that the activation of PPAR-α induced the 
transcription of LPL [15] and fatty acid transporters (FAT/CD36) [14]. PPAR-γ is 
specifically expression in adipose tissue and plays an important role in adipose tissue. It 
was increased in both mRNA and protein level in response to HF diet [23]. The 
activation of PPAR-γ leads to lower plasma glucose concentration in T2DM patients [24, 
25] while the deletion of PPAR-γ gene in adipose tissue causes reduced adipocytes 
number accompany with elevated plasma FFA and TAG concentration [26, 27]. Major 
enzymes related to fat accumulation such as acetyl CoA carboxylase (ACC) and 
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glycerol-3-phosphate dehydrogenase (GPDH) are increased in adipose tissue in 
response to HF diet [23]. Once the influx of FAs exceeds the storage capacity of 
adipose tissues, excessive FAs will efflux to other organs including liver and muscle 
[28].  
Liver is a critical organ involved in lipid metabolism and can be greatly affected by 
long-term HF diet. mRNA expression associated with hepatic lipid metabolism, including 
Fasn, Srebp1a, Cpt1a and Pparα [17, 21], can be altered by HF diet. The expression 
level of Fasn and Srebp1a were significantly decreased in liver of rats fed a HF diet 
(60% calories from fat) for 4 months[17], indicating that a HF diet has an inhibition 
impact on genes for fatty acid synthesis and lipogenesis. The expression of genes 
involved in hepatic lipid catabolism were affected by HF diet through epigenetic 
modification, such as PPAR-α, Cpt1a. It was reported higher expression levels of 
PPAR-α in HF-fed rat as correlated with increased expression of Cpt1a together with a 
rise in triacylglycerol content in the liver [21]. Several animal models of HF diet have 
demonstrated that HF was a major cause of chronic liver diseases, such as steatosis, 
as increased fatty acid flux into liver and over-accumulation of hepatic fat [29, 30].  
Muscle is the major organ of FA oxidation. Some studies indicated that HF diet 
reduced expression of genes in FA synthesis (Fasn, Srebp) and increased expression 
of genes in FA uptake (CD36, LPL) and oxidation (Cpt1, PPAR-α) in muscle [17, 21, 
31]. However, the effect of HF diet on FA catabolism related genes in muscle is still 
controversial. Some studies showed an increased expression of FA oxidation [32] while 
others showed a decreased expression of FA uptake (Pgc1-α) [33]. 
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In summary, HF diet exposure has vital influence on lipid metabolism in different 
organs by regulating the expression of genes related to FA uptake, synthesis, and 
oxidation. Different organs may response to HF diet in different ways in terms of the 
roles they play in lipid metabolism. Moreover, the composition of fat can alter the 
metabolic responses to HF diets. 
Lipoprotein Lipase 
A variety of regulation factors has been defined in different animal models 
undergone long-term HF diets. To determine the importance of lipolytic and lipogenic 
modification in response to HF diets, clarifying the epigenetic mechanism behind the 
regulation of lipid metabolism in main organs takes the priority. 
Lipoprotein lipase (LPL) is a member of human lipases existing in endothelium 
where it hydrolyzes TAGs in chylomicron and VLDL. It is essential for TAG hydrolysis in 
chylomicrons and VLDLs. Specifically, LPL is produced in parenchymal cells, 
translocated to the vascular surface of the capillary endothelium with the participation of 
the apolipoprotein C-II and glycosylphosphatidylinositol-anchored high density 
lipoprotein-binding protein 1 (GPIHBP1) and acts at ‘binding-lipolysis sites’ on the 
vascular surface of the endothelial cells [34]. Normally, LPL interacts with substrates by 
the N-terminal domain to finish catalysis. It was overexpressed in mice fed HF diets 
enriched in saturated fat for 12 weeks and overexpression of LPL accelerates FA 
uptake, which ultimately develops into insulin resistance in mice [18, 35]. 
LPL is primarily synthesized in multiple tissues such as skeletal muscle, adipose 
tissues, macrophages, the nervous system, and liver [36]. It hydrolyses lipids for 
different purposes in different tissues. In heart and skeletal muscle, LPL produces FFA 
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from plasma lipoproteins for beta-oxidation [37]. In adipose tissue, LPL hydrolyzes 
TAGs in lipoproteins and generates FFA for lipid storage, where LPL is an important 
factor for obesity development [38].  
LPL expression can be regulated through both transcriptional and post-
transcriptional mechanisms while the activity of LPL protein depends on the interaction 
with other proteins in specific tissues [39]. Dietary factors and nutrient states can alter 
LPL expression directly or indirectly through complex mechanisms at multiple levels 
[36]. Genomic analysis found the upstream region of LPL genes from transcription site 
contains several transcriptional binding elements, including the peroxisome proliferator 
activated receptor responsive element (PPRE) [40-42]. Peroxisome proliferator 
activated receptors (PPARs) can specifically bind to PPRE site in the target genes and 
regulates target gene expression. For LPL expression, PPARs bind to the PPRE in the 
LPL promoter in the form of PPAR-RXR heterodimer, a combination of PPARs and 
retinoic receptor (RXR), and active LPL expression in a tissue-specific manner [42]. In 
addition to PPARs, RXR can dependently up-regulate LPL expression in plasma, 
skeletal muscle, and heart, but not in adipose tissue [43]. Some other studies reported 
tumor necrosis factor (TNF), protein kinase A (PKA) inhibited LPL transcription while 
transforming growth factor-beta (TGF-beta) induced LPL transcription[44-46]. 
Recently, microRNAs are considered as important regulatory factors for post-
transcriptional suppression of LPL by complimentarily binding with the 3’UTR of LPL 
mRNA. miR-29a/b can inhibit LPL expression in dendritic cells and mammary epithelial 
cell (MEC) respectively [47, 48]. Further research illustrated that miR-27a/b and miR-
467b inhibited the LPL transcription in THP-1 macrophages and RAW 246.7 
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macrophages respectively [49, 50] and the inhibitory effect of miR-27 and miR-29 is 
synergetic [51]. 
Interaction proteins can also affect the biological function of LPL. For example, 
apoA-V promotes LPL catalytic effects by enhancing attachment of lipoproteins to 
GPIHBP1, the major platform form for LPL catalysis [36]. Additionally, angiopoietin-like 
protein 4 (Angptls 4) downregulated LPL activity through dimer-to-monomer conversion 
of LPL protein and competitive inhibition [52]. Other members of Angptls were 
subsequently found to inhibit LPL activity through Angptl3-4-8 model [53]. 
In summary, LPL is essential for TAG hydrolysis and FFA generation from TAG-rich 
lipoproteins. FFAs generated by LPL are utilized for different subsequent metabolism 
purpose following tissue-specific manners. Therefore, LPL plays an important role in 
lipid metabolism. The regulation of LPL is complex and varies in specific tissues. Dietary 
factors alter the expression of LPL through different mechanisms at multiple levels and 
ultimately impact lipid metabolism.  
MicroRNAs and the function in lipid metabolism 
MicroRNAs (miRNAs) are small non-coding RANs with 19-22 nucleotides that 
serves as post-transcriptional regulators of genes. They transcriptionally regulate gene 
expression by binding to 3’ untranslated region (UTR) of specific mRNAs bases on 
complementary sequences and cause inhibition of translation or mRNA degradation 
[54]. The existing of microRNAs was first observed in the cytoplasm of C. elegans as 
short antisense RNAs binding to mRNAs [55]. Subsequently, a growing number of 
microRNAs was identified in diverse species, including human, mouse, rat, in quick 
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succession. Further studies found the general negative regulatory effect of microRNAs 
on mRNAs and the highly conserved sequences of microRNAs across different species, 
identifying that microRNAs take a major place in post-transcriptional regulation [56].  
The formation of mature miRNAs goes through two steps. First, the nascent miRNA 
transcripts (pri-miRNA), transcribing from one strand of miRNA gene by RNA 
polymerase II [57], are processed into ~70-nucleotide precursors (pre-miRNA) by 
Drosha, a RNase-III enzyme predominantly localized in the nucleus. This pre-miRNA 
consists of an imperfect stem-loop structure. It is subsequently cleaved into ~21-25-
nucleotide mature miRNAs by Dicer, another RNase-III enzyme located in the 
cytoplasm [58]. After cleaved by Dicer, the asymmetrical hairpin pre-miRNA generates a 
small, imperfect dsRNA duplex which contains two short RNA strands. One of the 
strands is the mature miRNA and the other one is the complementary strand of the 
miRNA [59-61].  
However, little is known about the transcriptional regulation of pri-miRNAs except 
certain miRNAs located within host genes. The host genes for miRNAs are either 
protein coding genes or noncoding RNA transcription units in mammalians [62]. In some 
cases, these miRNAs within host genes are transcribed in parallel with their host 
transcripts, indicating the transcription of these miRNAs is regulated by the promoter 
regions of their host genes [3, 63]. However, the transcription of miRNAs and host 
genes can also be uncoupled with separate promoters and processing procedures. 
Certain genome wide analyses focus on identifying the promoter regions of human 
miRNAs. These studies show that about 30% of intronic miRNAs transcribe with 
alternative promoters. These independent promoters of miRNAs can be located 
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thousands of nucleotides of the upstream of the miRNA sequences. Additionally, many 
of these promoters contains the TATA box which was found in protein coding genes 
[64-67].Transcription factors to miRNAs can be predicted based on genome wide 
survey. Interestingly, the genome wide survey reports that in some cases, the 
transcription factors are in turn the target of the miRNAs that they regulate, indicating 
the existing of feedback loops in miRNA transcriptional regulation [68]. 
Some miRNAs locate close in the intron of the host gene and transcribed together 
as one transcriptional unit called a “cluster” [4, 69]. These miRNAs usually share 
identical seed sequence and are defined as members of a miRNA family, like miR-29 
family [70].  
Numerous studies have already established the role of miRNAs in cell growth, 
differentiation, and apoptosis. However, recent studies are attaching great importance 
to the role of miRNAs in lipid metabolism. Lipid metabolism involves in several organs 
including adipose tissues, and each organ has unique miRNA expression profile. In 
adipose tissues, miR-14 is the first miRNA reported to involve in lipid metabolism in 
Drosophila [5]. Flies lacked in miR-14 had enlarged lipid droplets with elevated levels of 
TAGs and DAGs while the overexpression of miR-14 showed the converse effects. In 
mammalians, several miRNAs are reported to regulate lipid metabolism in adipose 
tissues such as miR-125a-5p [71], miR-155 [72], miR-103, miR-143 [73]. The 
expression of miRNA-125a-5p mediates lipid uptake in macrophages [71]. miR-103 and 
miR-143 leads to increase the expression of PPAR-γ2, and miR-103 increases the 
expression level of fatty acid binding protein 4 (FABP4) [73]. miR-33 family members 
are key regulators in lipid metabolism. miR-33a and miR-33b locate in introns of their 
11 
 
target genes, SREBP-2 and SREBP-1, respectively and regulate SREBP expression. 
SREBP regulates cholesterol synthesis through transcriptional regulation of LDL-c 
receptors [74].Additionally, overexpression of miR-33a/b inhibits FA oxidation [75]. miR-
93 is supposed to regulate the replacement of preadipocytes and adipocytes in visceral 
white fat through the inhibition of Sirt7 and Tbx3 [76]. The activation of the target genes 
of Sirt7 increases fatty acid uptake and triglyceride synthesis or storage. Besides the 
miRNAs reported above, the functions of bunches of miRNAs in lipid metabolism in 
adipose tissue are still under research. 
In addition to adipose tissue, miRNAs alter in other tissues in response to HF diet 
including liver, skeletal muscle, and endothelium. Studies showed that miR-467b 
regulated lipid metabolism by affecting the expression of hepatic lipase (HL) in C57BL/6 
mice. HF diet reduced the expression of miR-467b accompanied by increased level of 
HL and increased risk of hepatic steatosis [11]. This group also reported that HF diet 
downregulated miR-21 expression in liver from mice accompanied with upregulation of 
fatty acid binding protein 7 (FABP7), a potential target of miR-21 [77]. Overexpression 
of FABP7 was observed in hepatic steatosis but the function of FABP7 in liver remain 
unknown [77]. miR-122 is another miRNA related to lipid metabolism through serum 
cholesterol regulation and is highly abundant in liver [78]. In hepatic cell lines, the 
overexpression of miR-33s reduced fatty acid oxidation by targeting at the mRNAs of 
key enzymes in fatty acid oxidation including carnitine O-acetyltransferase (CROT) , 
carnitine palmitoyltransferase 1a (Cpt1a), hydroxyacyl-CoA-dehydrogenase, Sirtuin-6 
(SIRT6), and AMP kinase subunit-α while the inhibition of miR-33s acted conversely 
[79]. In skeletal muscle, there are only a few studies reported miRNAs related to lipid 
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metabolism to date. Several studied reported miR-1, miR-133a/b and miR-206 were 
downregulated and miR-144, miR-106b were upregulated in response to HF diet [80]. In 
endothelial tissue, miR-29b [81], miR-1 [82] and miR-155 [83] appears to play an 
important role in the development of cardiovascular diseases following HF diet. The 
expression of these miRNAs is downregulated in response to HF diet in most animal 
models [81-83].  
In summary, miRNAs are widely related to the post-transcriptional regulation of 
genes related to lipid metabolism in different tissues following HF diet. The mechanisms 
that miRNAs regulate lipid metabolism are complex and vary across different tissues. 
The link between miRNAs and lipid metabolism is waiting to be investigated. 
miR-29 families 
The miR-29 family consists of miR-29a, miR-29b and miR-29c, sharing the same 
seed sequences. The genes encoding the precursors of miR-29 families locates on 
different chromosomes. The DNA sequences for miR-29a and miR-29b-1 locates on the 
reverse chain on chromosome 6 in mouse and on chromosome 7 in human, while the 
DNA sequence encoding miR-29c and miR-29b-2 locates on the forward chain on 
chromosome 1 in both mouse and human. Mature miR-29b-1 and miR-29b-2 share the 
same RNA sequences. miR-29s located at the same chromosome are transcribed 
together as a polycistronic primary transcript [9]. 
For miR-29a/b-1 transcripts, they can be encoded by either the last exon or last 
intron of the primary transcripts in human, while miR-29b-2/c can only be encoded by 
last exon of the primary transcripts in human [9, 84]. Different process of slicing 
influence the regulation of the transcription of miR-29s but yields the same mature miR-
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29s [85]. The sequences of mature miR-29 family members are highly conserved with 
the identical seed region AGCACC across various species, including human, rat, and 
mouse. 
Recent studies have reported several factors regulating miR-29 expression through 
transcriptional regulatory mechanisms. Chromatin immunoprecipitation analysis 
demonstrated the binding of c-Myc in the promoter regions of both miR-29a/b-1 and 
miR-29c/b-2 in human cell lines and the binding of c-Myc represses the expression of 
miR-29s [9]. The overexpression of c-Myc contributed a decreased RNA level of miR-
29s in human and mouse models of B cell lymphoma [9]. Further studies reported the 
potential interaction between c-Myc and histone deacetylase 3 (HDAC3), histone-lysine 
N-methyltransferase 2 (EZH2), which cooperatively contributed to the repression of 
miR-29 transcription in B-cell lymphomas (BCLs) [10]. Additionally, there was a positive 
feedback loop between the expression of c-Myc and EZH2 where c-Myc upregulated 
EZH2 and EZH2 induces c-MYC in turn.  
In addition to c-Myc, studies also identified several binding sites on the promoter 
region of miR-29s for transcriptional regulation and several signaling pathways that 
involved in miR-29 regulation. Mott et al. identified a Gli-binding site, and four NF-κB-
binding sites on human miR-29b-1/miR-29a promoter region in cholangiocarcinoma 
cells, suggesting that miR-29b-1/miR-29a was suppressed by the activation of c-Myc, 
hedgehog, and TLR/NF-κB signaling pathways [84]. Furthermore, NF-κB can also 
suppress the expression of miR-29b-2/miR-29c through NF-κB-YY1-miR-29 circuitry 
where YY1 is a transcriptional target of NF-κB and it repressed miR-29b-2/miR-29c by 
binding at miR-29b-2/miR-29c promoter region in mouse myoblasts and finally affected 
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myogenesis [86]. Qin et al. reported that miR-29b-2 was downregulated by TGF-β (1) 
and the repression was mediated by Smad3 which binds to conserved sequences at the 
promoter of miR-29b-2 in human myeloid cells [87]. Canonical Wnt signaling pathways 
can also regulate miR-29a transcription. There was two potential T-cell factor/LEF-
binding sites within the proximal promoter of human miR-29a, and the transcriptional 
factors can be activated by β-catenin during canonical Wnt signaling in hFOB1 cells 
[88]. Other factors, for example, CCAAT/enhancer binding protein alpha (CEBPA), may 
activate miR-29a/b-1. There is a CEBP binding site on miR-29a/miR-29b-1 locus in 
chromosome 7, and the absence of CEBPA causes silencing of miR-29a/b-1. Notably, 
the CEBPA only activates miR-29a/miR-29b-1 on chromosome 7 while has no effect on 
miR-29b-2/miR-29c on chromosome 1[89].  
MiR-29 family members suppress the gene expression by binding to 3’UTR of target 
mRNAs as other microRNAs. The target mRNAs of miR-29 that have been investigated 
related to cell proliferation, differentiation, apoptosis [10, 86, 88], extracellular matrix[90-
93], and lipid metabolism [7, 8, 94, 95]. In this way, miR-29s play important roles in the 
development of several diseases, including cancers, fibrosis, diabetes, and 
dyslipidemia.  
MiR-29s are downregulated in several types of cancers, thereby, they serve as 
tumor suppressors in most studies [9, 84]. Studies reported that reduced miR-29s 
expression in cancers cells further deteriorated the cancer development, suggesting the 
restoration of miR-29s can be a novel potential therapy of several types of cancers [96, 
97]. Garzon et al. conducted a study in acute myeloid leukemia and confirmed the 
beneficial effect of exogenous miR-29 treatment [97]. The restoration of miR-29b in 
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acute myelogeneous leukemia (AML) cells reduced cell growth and induced apoptosis 
while the overexpression of miR-29b inhibits leukemic growth in a xenograft model [97]. 
In addition to cell proliferation and apoptosis, miR-29s also contribute to cell 
differentiation. The down regulation of miR-29 during myogenesis accelerated 
differentiation in Rhabdomyosarcoma (RMS) cells by targeting at YY1, which was also a 
suppressor of miR-29 as reported in this study, indicating that miR-29 plays an 
important role in regulating cell differentiation [86]. Another study performed in the 
mesenchymal precursor cell line hFOB1.19 and human osteoblasts also showed that 
miR-29a is essential for mediating human osteoblast differentiation by downregulating 
Wnt signaling antagonist and enabling Wnt signaling [88].  
Although most previous researches focused on the regulation mechanism of miR-29 
family members in cancer development, there is an increased number of studies 
revealed the role of miR-29s in lipid metabolism. Lipoprotein lipase, encoding by LPL 
gene, is a key enzyme in lipid metabolism for TAGs hydrolyzation in multiple tissues. 
Bouvy-Liivrand et al. reported that the mRNA levels of lipoprotein lipase (LPL) were 
inversely correlated with the expression level of miR-29a, indicating LPL is a potential 
target of miR-29a in 3T3-L1 adipocytes. In their study, complete LPL-3’UTR was cloned 
into a psiCHECK-2 plasmid and the results from luciferase assay confirmed that miR-
29a inhibited LPL mRNA transcription by interacting with LPL-3’UTR [7]. Another study 
performed in mammary epithelial cell (MEC) supplemented the inhibition effect of miR-
29b on LPL [8]. Moreover, caveolin2 (CAV2), a gene encoding protein related to lipid 
metabolism, was also a validated target of miR-29 family in adipose tissues [98]. 
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In summary, miR-29 family members participate in many metabolic processes by 
regulating either upstream signaling pathways or downstream target genes. The 
metabolic changes can alter the transcription of miR-29s by activating transcription 
factors that have specific binding sites on miR-29 promoters. On the other hand, miR-
29s can in turn downregulate their direct target genes through the conserved seed 
sequences in 3’UTR of the target genes. At present, most studies focus on the role that 
miR-29 family plays in different types of cancers, there is a growing interest from 
researchers in the function of miR-29 family in lipid metabolism. 
c-MYC proto-oncogene 
c-Myc is a transcription factor regulating expression of genes that control cell growth 
and proliferation [99]. It belongs to the Myc family that includes b-Myc, c-Myc, l-Myc, n-
Myc and s-Myc. However, only c-Myc, l-Myc and n-Myc are oncogenes that have ability 
to promote tumorigenesis [99]. Most studies focus on the role of c-Myc in cell cycle 
progression, which is associated with cancer development.  
C-Myc plays a role in glycolysis, glutaminolysis, nucleotide biosynthesis, lipid 
synthesis, mitochondrial biogenesis, and cell cycle progression. Increased expression of 
c-Myc in liver promotes liver regeneration by preceding DNA synthesis and transiting 
hepatocytes from G0/G1 to the S phase [100]. C-Myc is commonly elevated in most 
cancers. The predominant impact of high c-Myc expression on microRNA is widespread 
suppression of microRNAs, which in turn contribute to tumorigenesis [9]. C-Myc acts as 
a transcription factor of cellular glucose and glutamine metabolism by activating the 
transcription of genes related to aerobic glycolysis and glutamine metabolism. Genes 
with strong Myc binding including lactate dehydrogenase alpha (LDH-α), enolase 1 
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(ENO1), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), hexokinase 2 (HK2), 
lactate dehydrogenase A (LDHA), 6-phosphofructokinase (PFKM) and triosephosphate 
isomerase (TPI1)  are upregulated by c-Myc in rat fibroblast cells, human lymphoid cells 
and human breast epithelial cells [101, 102]. Glutaminase (GLS) mRNA levels are 
elevated with c-Myc induction. C-Myc can inderectly induce GLS mRNA levels by 
binding to the promoter region of C9orf3, the host gene of miR-23b, and represses miR-
23b transcription in human P943 cells. MiR-23b subsequently suppresses the synthesis 
of GLS [103]. Other glutamine transporters such as ASCT2 and SN2 are transcriptional 
regulated by c-Myc in vitro [104]. The regulation of glycolysis and glutamine metabolism 
by c-Myc is coordinated with nucleotide synthesis for cell proliferation [105, 106]. 
Moreover, genes related to fatty acid synthesis such as acetyl-CoA carboxylase (ACC), 
fatty acid synthetase (Fasn), and stearoyl-CoA desaturase (SCD) are potential targets 
of c-Myc as measured by global gene expression analysis [107]. Notably, Fasn and 
SCD are regulated by SREBP as reported in several studies [108, 109]. However, both 
Fasn and SCD also contained conserved binding elements of c-Myc [106], indicating 
the existing of c-Myc may activate genes involved in fatty acid synthesis independent 
from SREBP. Induction of c-Myc expression is cooperated with increased mitochondrial 
mass and gene expression of mitochondria biogenesis, such as PGC-1β [110-112]. 
These studies indicated that relationship between c-Myc and mitochondria biogenesis. 
C-Myc is post-translationally regulated by mTOR, which stabilizes the c-Myc protein 
and promotes c-Myc translation [113]. Several studies showed that mTOR inhibitors 
downregulated c-Myc protein levels in different models [114, 115]. Here, mTOR is a 
downstream gene of PI3K-AKT pathway that can be stimulated by growth factors such 
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as insulin, amino acids and inhibited by low energy (high AMP/ATP ratio) and WNT 
signaling [116, 117].  
In summary, c-Myc is a primary transcription factor that involves in numerous cellular 
metabolism process and cell cycle progression. It can regulate the transcription of 
mRNA and microRNAs at transcriptional level. At present, most studies focus on the 
role of c-Myc in various type of cancer models and have great interest in c-Myc 
regulation of glycolysis, glutamine metabolism and nucleotide synthesis. However, c-
Myc provide a novel regulatory mechanism of lipid metabolism by targeting at specific 
sets of genes involved fatty acid synthesis and regulated these genes independent from 
SREBP. 
Conclusion 
Chronic HF diet has vital impact on lipid metabolism by regulation FA catabolism 
and anabolism process. Aberrant expression of genes related to lipid metabolism can 
cause metabolic disorders and chronic diseases such as obesity, type 2 diabetes, and 
cardiovascular diseases. Liver, adipose, and skeletal muscle are organs that can be 
affected by HF diet notably because of the roles they play in lipid metabolism. Previous 
studies have shown the significant and specific impacts of HF diet on lipid metabolic 
gene expression in these organs. It remains elusive about the mechanism that HF diet 
impacts metabolic function in these organs. 
miRNAs regulate metabolism in most mammalian tissues including adipose tissues 
through complimentary pairing between ‘seed’ region of miRNAs and 3’UTR of their 
target genes. It was reported that miR-103, miR-143, miR-33a, and miR-29s have been 
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implicated as regulator of PPAR-γ, SREBP2, LPL, respectively. However, the impact of 
HF diet on lipid metabolic function in adipose tissues has not been completely studied. 
The information about transcriptional regulation of miRNAs is limited. Certain 
miRNAs located within host genes may transcribe parallel with their host genes though 
the same promoter. The transcription factors and promoter regions of the miRNAs 
involved in lipid metabolism are needed to be identified under the HF condition. 
To further investigate this topic, we plan to study the regulatory mechanism of lipid 
metabolic genes in adipose tissues from HF-fed mice. Post-transcriptional regulation of 
genes involved in lipid metabolism will be investigated. Furthermore, the transcriptional 
regulation and transcription factors of miRNAs involved in lipid metabolism will also be 






Chapter 3: Epigenetic Regulations of Genes Related to Lipid 
Metabolism by MicroRNA in Mice Fed High Fat Diet 
Introduction 
Environmental factors such as diet patterns, exercise, drugs, and radiation play an 
important role in the development of diverse chronic diseases. Diet is one of the critical 
factors contributing to the origin of these diseases. Long-term high fat (HF) diet causes 
the accumulation of fat droplets for extra triglyceride storage in multiple tissues including 
liver, adipose, and muscle. Fat accumulation in adipose tissue due to the increases size 
and number of adipocytes resulting in body weight gain and obesity. Moreover, the 
excessive adipocytes impacts the normal lipolytic and secretory function of adipose 
tissue, leading to inflammation [118, 119], insulin resistance [120] and other metabolic 
diseases. Abnormal lipolytic function of adipose tissue subsequently release greater 
amount of free fatty acids into blood causing high triglyceride levels in blood. 
Triglycerides in blood can flux to liver and muscle through blood circulation and cause 
fat accumulation in the liver and muscle [121, 122]. 
Lipoprotein lipase (LPL) is primarily synthesized in parenchymal cells of various 
tissues including skeletal muscle, adipose tissues, and liver [36]. Once synthesized, it is 
translocated to the vascular surface with the participation of the apolipoprotein C-II and 
glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 
(GPIHBP1) and acts at ‘binding-lipolysis sites’ on the vascular surface of the endothelial 
cells in tissues [34]. Overexpression of LPL accelerates TAG hydrolysis and FA uptake. 
In adipose tissues, increased TAG hydrolysis causes lipid storage and enlarges 
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adipocytes [38]. While in muscle, FFAs generated from plasma lipoproteins by LPL are 
oxidized to provide energy through beta-oxidation in mitochondria [37].  
LPL can be regulated through both transcriptional and post-transcriptional 
mechanisms. Some transcription factors regulate the LPL expression by binding to 
specific binding sites on the promoter of LPL gene. For example, peroxisome 
proliferator-activated receptors (PPARs), one of the transcription factor of LPL, up-
regulated the expression of LPL by dimerizing with the retinoic acid receptor (RXR), and 
binding to the peroxisome proliferator activated receptor responsive element (PPRE) in 
the promoter of LPL gene [42]. Besides the transcriptional signaling pathways, LPL 
expression is also post-transcriptionally regulated by microRNAs through 
complementary alignment between the 3’UTR of LPL mRNA and the seed region of 
regulation microRNA [95]. Seed sequences of miR-29a/b, miR-27a/b and miR-467b are 
complimentary to the 3’UTR sequences of LPL and the inhibitory effects of these 
miRNAs on LPL has been observed in vitro [47-50]. 
Decreased expression of miR-29s has been observed in endothelial tissue following 
HF diet [123]. The mechanisms regulating expression of miR-29s are of interest. 
Although little is known about transcriptional regulation of miRNAs, recently, c-Myc was 
shown to contribute to miR-29s suppression in human cell lines [9, 10]. HDAC3 and 
EZH2 are also involved in transcriptional regulation of miR-29. These two transcription 
factors combine to form HDAC3-EZH2 complex that cooperatively regulate miR-29s 
with c-Myc in B-cell lymphomas (BCLs) [10]. In addition to c-Myc, other transcriptional 
binding sites, such as NF-κB, were found in human miR-29a/b-1 promoter region in 
human cholangiocarcinoma cells[84]. 
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c-Myc is a transcription factor controlling cell growth, apoptosis, and metabolism by 
regulating relative genes at transcriptional levels. In various types of cancers, c-Myc 
binds to proximal promoter regions of genes regulating DNA replication, induces mRNA 
transcription and ultimately contributes to tumorigenesis [124]. However, c-Myc mainly 
acts as a negative transcription factor in microRNA regulation [9, 125]. MicroRNA 
expression levels were measured in the high and low c-Myc states in human B cells and 
the results showed lower microRNA levels in high c-Myc states including miR-29s while 
higher microRNA levels in low c-Myc states. It is reported that EZH2, an enzyme 
participates in histone methylation and eventually causes transcription repression, also 
participated in repression of miR-29s transcription. In B-cell lymphomas (BCLs), c-Myc 
may recruit EZH2 and repress miR-29 expression together [10]. Moreover, there are 
feedback loops existing between some microRNAs and c-Myc [125]. 
The present study was designed to investigate the regulation of lipid metabolism 
related genes mediated by transcription factors and microRNAs in response to high fat 
diet. We hypothesize that HF diet represses the transcription of miR-29 by activating the 
negative transcription factors and the reduced miR-29 expression leads to high mRNA 
level of its target gene, LPL, in adipose tissues in mice fed HF diet. 
Experiment Methods 
Animals and treatments 
Four-week old male CBA mice (The Jackson Laboratory) were separated into two 
dietary groups and fed either control diet (10% kcal from fat, n=12) or high fat diet (45% 
kcal from fat, n=14) for 11 weeks. Mice were kept in standard polycarbonate cages (4 
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mice per cage) in a humidity- and temperature-controlled room on a 12-h light-dark 
cycle, with ad libitum access to food and drinking water. Body weight and food intake 
were recorded every 7 days and magnetic resonance imaging (MRI) was conducted 
monthly during treatment. Mice were sacred after 11 weeks of treatment. The liver, 
muscle, adipose and colon was snap-frozen in liquid nitrogen and stored at −70°C for 
future use.  
RNA isolation and quantitative reverse transcription-PCR analysis  
All mice tissues were ground in liquid nitrogen and lysed with Trizol Reagent (Life 
Technologies). Total RNA was isolated with Directzol RNA Miniprep Kit (Zymo 
Research), according to the manufacturer’s recommendations. Total RNA concentration 
was quantified spectrophotometrically (NanoDrop ND-2000 Spectrophotometer; Thermo 
Fisher Scientific, Waltham, MA). RNA was reverse-transcribed to cDNA using High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Real-time PCR was 
performed in a 10 μL reaction volume containing 5 μL POWER UP SYBR green master 
mix (2×, Applied Biosystems), 0.4 μL of each forward and reverse primers (5 μmol/L), 
and 5 ng cDNA template by cycling at 50 °C for 2 min and 95 °C for 2 min followed by 
40 cycles of 95 °C for 15 sec and 60 °C for 1 min in a StepOnePlus real-time PCR 
system (Applied Biosystems). After amplification, melting curves were acquired 
stepwise from 55 to 95 °C to ensure that a single product was amplified in the reaction. 
Primer sequences, synthesized by Integrated DNA Technologies, are reported in 
Appendix 1. Geometric mean of mRNA levels of L7a, GAPDH, and beta-actin were 
used as an internal control to normalize raw data. 
TaqMan® MicroRNA Assays 
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RNA isolation follows the same steps as mRNAs. MiR-29a and miR-29b were 
reverse transcribed into cDNA using TaqMan Micro RNA Reverse Transcription Kit 
(Applied Biosystems; Foster City, CA) and specific primers from TaqMan™ microRNA 
Assays (5×, Applied Biosystems). Real-time PCR was performed in a 10 μL reaction 
volume containing 5 uL TaqMan® Fast Advanced Master Mix (2×, Applied Biosystems), 
0.5 uL each primer from TaqMan™ microRNA Assays (20×, Applied Biosystems), and 
0.25 ng cDNA template by cycling at 50 °C for 2 min and 95 °C for 10 min followed by 
40 cycles of 95 °C for 15 sec and 60 °C for 1 min on a StepOnePlus real-time PCR 
system (Applied Biosystems). TaqMan microRNA primer sequences are reported in 
Appendix 2. Expression level of U6 was used as an internal control to normalize raw 
data. 
Transcription factor prediction 
Three online programs, NCBI (http://www.ncbi.nlm.nih.gov/), UCSC 
(http://www.genome.ucsc.edu/), and Ensembl (http://www.ensembl.org/index.html), 
were  used for promoter search of mus-miR-29a. Also, the JASPAR 
(http://jaspar.genereg.net/) and Enhancer Element Locator analysis 
(http://www.cs.helsinki.fi/u/kpalin/EEL/) are applied to predict the transcription factor 
binding site. 
Chromatin Immunnoprecipitation (ChIP) 
For ChIP analysis, 400 mg of adipose tissues were used per sample. Six different 
samples were used for each treatment group. Adipose tissues were ground in liquid 
nitrogen and suspended in 1x PBS buffer. Protein and DNA were cross-linked by adding 
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formaldehyde directly to a final concentration of 1%. Cross-linking was stopped 10 min 
later by adding 2 mol/L glycine to a final concentration of 0.125 mol/L. Cross-linked 
chromatin was solubilized by sonication using a Sonic Dismembrator (Model 100, Fisher 
Scientific Co.) for five bursts of 40 s at 50% of maximum power output with 2 min 
cooling on ice between each burst. The chromatin immunoprecipitation procedure used 
was previously described follow a modified protocol [126, 127]. Briefly, solubilized 
chromatin was diluted 1:10 with dilution buffer. Normal rabbit IgG was used as a 
negative control for the immunoprecipitation procedure. Antibodies against c-Myc 
(#13987) and EZH2 (#5246) were purchased from Cell Signaling Technology (Danvers, 
MA). The antibody was incubated with Dynabeads Protein G (thermos fisher scientific) 
at 4 °C overnight to form antibody-magnetic beads complex. The amount of antibody 
used for incubation follows the usage information from manufacturers. 1 mL diluted 
sample solution containing sheared chromatin was added to magnetic beads complex 
and incubated at room temperature for 2 hours. Pellets containing the 
immunoprecipitated complexes were washed subsequently with 1 mL of low salt wash 
buffer, high salt wash buffer, LiCl salt wash buffer and twice Tris-EDTA (pH=8.0). The 
immunoprecipitated complexes with antibody, protein and DNA were eluted from 
magnetic beads by adding twice 250 μL of elution buffer and shaking in incubator 
shaker (model EXCELLA E24R, Eppendorf company) at 37 °C, 300 rpm for 15 min. The 
DNA fragments in the immunoprecipitated complex were released by reversing the 
cross-linking at 65 °C for 5 h with 20 μL 5 mol/L NaCl and 1 μg of RNase A (Qiagen, 
Hilden, Germany). Proteins were removed from DNA fragments by treating with 
proteinase K (Sigma) at 37 °C for 1 h. DNA fragments were purified using a QIAprep 
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Spin Miniprep Kit (Qiagen). Purified DNA was analyzed using quantitative real time PCR 
with primers covering potential promoter regions of miR-29a/b-1 and miR29b-2/c. The 
sequences of primers are displayed in Appendix 3.  
Statistical analysis 
 A Student’s t-test was used to detect the significant differences between the treated 
group and the control group. A P value of less than 0.05 was considered significant. All 
data are means +/−SEM. 
Results 
High Fat Diet Induces Body Weight Gain and Increases Fat Percentage in Mouse 
The body weight and fat percentage of mice in either control or HF group were recorded 
at birth. There were no significant differences between two treatment groups. After 
treatment, mice consuming HF diet showed more body weight gain when compared to 
those consuming control diet. The difference in body weight gain between control and 
HF group became significant after feeding for 8 weeks. The fat percentage of mice fed 
HF diet was higher than those fed control diet after 1-month treatment. 
High Fat Diet Induces LPL mRNA Expression in Mouse Adipose, Muscle and Colon but 
not in Liver 
In the study, we investigated the expression of LPL in multiple tissues of mice from both 
Con and HF groups. Relative mRNA expression of LPL in adipose, muscle, liver and 
colon were measured using real time PCR (Fig. 1A). The baseline of LPL expression 
was highest in adipose, followed by muscle, and was lowest in liver and colon.  LPL 
27 
 
basic expression in adipose was 2-fold higher than that in muscle and was 142-fold 
higher than that in liver and colon. After HF treatment, mRNA of LPL significantly 
increased (P<0.05) in mouse adipose, muscle, and colon by 1.6-fold, 1.6-fold, and 4.6-
fold respectively, while decreased in liver by 0.5-fold (P<0.05). Furthermore, LPL 
expression was highest in adipose, followed by muscle, colon and lowest in liver after 
HF treatment. Altered LPL mRNA level in adipose was 2.8-fold higher than that in 
muscle, 45-fold higher than that in colon, and 458-fold higher than that in liver. As 
lipoproteins in liver were hydrolyzed hepatic lipoprotein lipase (HL), a liver specific 
lipase, we measured HL expression in liver. The expression of HL in both control and 
HF groups was also quantified (Fig. 1B). The results showed HL mRNA expression 
decreased in the liver of HF mice by 0.9-fold compared to control group, which 
paralleled LPL mRNA expression in liver. 
High Fat Diet Suppresses miR-29a/b Expression in Mouse Adipose 
MiR-29s potentially suppress the expression of LPL as there are conserved 
complimentary pairing between miR-29a-3p, miR-29b-3p and LPL 3’UTR (Fig. 2A and 
B). As adipose is a critical organ in lipid metabolism and expresses highest mRNA level 
of LPL, we explored alteration of miR-29a/b expression and relationship between miR-
29a/b and LPL expression in response to HF diet in adipose. The transcription of miR-
29 family members including miR-29a and miR-29b was measures in adipose tissues. 
miR-29a (P=0.06) and miR-29b (P<0.05) RNA level was decreased in adipose from HF 




High Fat Diet induces c-Myc binding at promoter region of miR-29s and Inhibits the 
Transcription of miR-29s cooperated with EZH2 in Adipose Tissue 
To identify potential negative transcription factors of miR-29s induced by HF diet, mRNA 
abundance of these transcription factors of miR-29s was analyzed in adipose tissues 
(Table. 2). mRNA levels of c-Myc, EZH2, NFkB1 were significantly elevated in the 
adipose of the HF group compared with the control group (P<0.05), which was inversely 
correlated with miR-29a and miR-29b expression in adipose tissue. It was reported that 
some of these transcription factors may act together to be involved in miR-29 
expression [10]. Then, we analyzed the promoter regions of miR-29a/b1 and miR-
29b2/c for binding sites and the results showed that there were four potential c-Myc 
binding sites in ~6 kb upstream of miR-29a/b1 (S1, S2, S3, and S4) and in ~6 kb 
upstream of the host gene of miR29b2/c (S1, S2, S3, and S4) in mouse (Fig. 3A). We 
investigated whether c-Myc and EZH2 binds to promoter regions of miR-29s and 
cooperatively repressed miR-29 transcription using chromatin immunoprecipitation 
(ChIP). The results showed that c-Myc and EZH2 bound to promoter regions of miR-
29a/b1 and miR-29b2/c (Fig. 3B-E). Moreover, both c-Myc and EZH2 bound to S2 of 
miR-29a/b1 and S1, S4 of miR-29b2/c and these bindings increased in response to HF 
diet (Fig. 3B-E). However, bindings of EZH2 were also increases in HF group at S3 of 
miR-29a/b1 and S3 of miR-29b2/c (Fig. 3D-E). Overall, c-Myc binding was significantly 
induced by HF diet at the promoter regions of miR-29s, including miR-29a/b1 (S2, 
P<0.05) and miR-29b-2/c (S1, S4, P<0.05) (Fig. 5B-C). Meanwhile, EZH2 also binds to 
promoter regions of miR-29s and the bindings increased in mice from HF group (Fig. 
5D-E). Part of EZH2 binding sites corresponded to c-Myc binding sites. The results 
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indicated that c-Myc and EZH2 cooperatively inhibited the transcription of miR-29s in 
the adipose tissues of mice fed HF diet. 
Discussion 
The present study reports a novel finding that a high fat diet activates the 
transcription of lipoprotein lipase in mouse adipose tissues through several epigenetic 
mechanisms. First, a high fat diet activates the transcription of transcription factors, c-
Myc and EZH2, leading to increased binding of these two transcription factors at the 
promoter region of miR-29s. C-Myc and EZH2 are negative transcriptional regulators of 
miR-29s and induced binding at promoter regions of miR-29s inhibits miR-29 
transcription. Reduced transcription of miR-29s causes elevation of its target gene, LPL, 
through post-transcriptional regulation in adipose tissues in response to high fat diet. 
Increased lipoprotein lipase expression lead to accelerated TAG hydrolysis and FA 
uptake in adipose, which may be one of the reasons for HF-induced weight gain and fat 
percentage induction. 
Lipoprotein lipases (LPL) is a critical enzyme associated with FA uptake in multiple 
tissues. LPL expresses in tissue-specific manners [40]. HF diet induces LPL expression 
in adipose tissue with the mediation of PPARγ [128]. LPL mRNA induction is more 
significant in female rats compared to male in adipose tissue [21]. The mRNA 
expression of LPL also increased in muscle in response to HF diet [21]. A study in 
obese mice showed that HF diet down-regulated LPL mRNA level in colon, which was 
consistent with the occurrence of obesity [129]. The alterations of LPL mRNA 
expression in adipose and muscle are consistent with our results showing a significant 
increase of LPL mRNA in adipose and muscle in mice fed HF diet. However, the 
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expression of LPL mRNA increased in colon in the present study. The results indicate 
that peripheral tissues including adipose, muscle and colon compensate excessive fat 
from diet by inducing lipoprotein lipase expression. Hepatic lipase (HL) is a liver 
specific-enzyme involved in liver lipid metabolism. There is a negative correlation 
between the liver HL level and the development of hyperlipidemia [130]. HF diet 
elevates TC, TAG and LDL-c in serum and significantly reduces the mRNA expression 
of HL in rats [131]. In the present study, we observed significant decreases of HL and 
LPL mRNA levels in liver even through the expression level of LPL in liver is much lower 
than that in other tissues. HL catalyzes TAG hydrolysis in chylomicron remnants and 
IDLs and facilities reverse cholesterol transport by providing HDL with apolipoproteins 
and phospholipids [132, 133]. Therefore, we speculate about the contribution of reduced 
HL levels to the accumulation of IDL in liver and the impairment of reverse cholesterol 
transport. 
LPL activity has been reported to be regulated by several biochemical mechanisms, 
including transcriptional and post-transcriptional regulation as well as protein interaction. 
MicroRNAs are post-transcriptional negative regulators by binding to their target 
sequences on 3’UTR. Luciferase expression with LPL 3’UTR allele combinations 
demonstrated the binding of miR-29, miR-1277 and miR-410 in HEK-293T cells [95]. 
Genomic screen in mice identified that miR-29a is a repressor of LPL in liver and the 
decreasing of hepatic miR-29a levels causes lipid accumulation in mice liver [134]. 
Another study showed that the luciferase expression decreased in mammary epithelial 
cells after miR-29b co-transfection with LPL gene report vectors, indicating miR-29b 
was also a suppressor of LPL [8]. In the present study, we observed a negative 
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correlation between LPL and miR-29a/b when comparing HF group to control group, 
indicating miR-29s are involved in LPL post-transcriptional regulation in adipose tissues 
from mice fed HF diet. Expression reduction in miR-29b was more significant than that 
in miR-29a, indicating miR-29b may play the domain role in LPL down-regulation.  
C-Myc is a master transcriptional regulator and potentially regulates more than 1500 
genes as compiled in Myc target gene database (www.myccancergene.org), including 
genes for normal mRNAs and microRNAs [9, 124, 135]. The activation of c-Myc is 
common in many cancers, which may contribute to cancer development by 
reprogramming the transcription of miRNAs related to tumorigenesis [9]. HF diet can 
also induce c-Myc in various animal models [136, 137]. The predominant consequences 
of elevated c-Myc level in human and mouse lymphoma cells are widespread 
suppression of miRNAs, including miR-15a, miR-16, miR-22, miR-26s, miR-29s and 
miR-30s [9]. Normally, c-Myc protein expression in adipose is low, but HF diet increases 
the protein expression of c-Myc in adipose tissues [138]. The data present here suggest 
that dietary fat abundance enhances c-Myc mRNA expression and engages repression 
of miR-29s by binding to the promoter regions of miR-29 clusters. Although members of 
the miR-29 family located at two different chromosomes, the data indicated that c-Myc 
bound to both chromosomes in response to HF diet. The results suggest that the 
induction of c-Myc and the binding of c-Myc at the promoter regions of miR-29s may be 
the mechanism that repress the transcription of miR-29a/b in adipose tissues from mice 
fed HF diet. Additionally, other transcription factor such as EZH2, NF-κB, HDACs, can 
also regulate the expression of miR-29s as other studies reported [10, 84, 139]. While it 
is reported that EZH2 could be recruited by c-Myc. EZH2 is an enzyme catalyzing 
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histone methylation. It is upregulated in multiple cancers and inhibits genes responsible 
to repress tumor development [140, 141]. In the present study, EZH2 is also 
upregulated and binds to the promoter regions of miR-29s in adipose from HF treated 
mice, indicating miR-29 repression is caused by histone methylation at the promoter 
region. Previous studies have showed that the downregulation of miR-122, miR-125b 
and miR-106 was associated with DNA methylation in liver injury [142], lower miR-200b, 
miR-152 and miR-10a expressions was related to higher DNA methylation in bladder 
cancer [143], and miR-10a was silenced because of abnormal DNA methylation in 
gastric cancer [144]. These publications indicate that DNA methylation may be an 
important factor regulating microRNA expression. Therefore, c-Myc and EZH2 may act 
together repressing the transcription of miR-29s through DNA methylation in HF-fed 
mice adipose.  
In summary, we have demonstrated that HF diet causes the activation of 
transcription factors, c-Myc and EZH2, and enhanced binding of transcription factors at 
the promoter regions of miR-29s in adipose tissue, which repressed transcription of 
miR-29a/b. Our study also demonstrated that miR-29a/b might be a post-transcriptional 
repressor of LPL in adipose tissue with HF treatment. Our study showed a potential 
model where HF diet induced LPL expression with c-Myc/EZH2 - miR-29 regulation in 
adipose tissue, which provides a potential connection between oncogenes and lipid 
metabolism.  
Future Study 
The results of the present study suggest that HF diet induces expression of LPL 
through c-Myc/EZH2 – miR-29 – LPL axis. As LPL hydrolyzes triglycerides in lipoprotein 
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and generates free fatty acids [40, 145], the induction of LPL in adipose, muscle and 
colon may cause an increased fatty acid influx in these tissues. Increased influx in these 
peripheral tissues will probably affect TAG synthesis and FA oxidation, which may be 
one of the causes for HF-induced dyslipidemia. Therefore, the current study provides a 
potential regulatory mechanism behind HF-induced dyslipidemia, which can be applied 
to study the therapy for dyslipidemia that intervenes the regulator function in this axis. 
For further study, the storage and oxidation of excessive fatty acid generated by 
overexpressed LPL in different tissues can be investigated by measuring TAG synthesis 
genes such as DGAT and β-oxidation genes such as Cpt1. Additionally, as the 
regulatory mechanisms by which miR-29b regulated LPL were studied in mammary 
epithelial cells [8]. Meanwhile, in present study, we observed inverse relationship 
between miR-29a/b and LPL in adipose from mice. Thereby, further study can be 
performed in vitro using adipocytes to test the binding of miR-29s at 3’UTR of LPL and 
confirm the post-transcriptional regulatory effect of miR-29s on LPL. Furthermore, this 
study reported c-Myc/EZH2 – miR-29 – LPL regulatory axis. Future study can focus on 
treatments for dyslipidemia caused by HF diet by targeting at this regulatory axis. For 
example, researchers can explore other transcription factors, histone proteins and DNA 
methylation involved in miR-29s regulation cooperated with c-Myc in adipose tissue 
under HF treatment. The reagents and drugs affecting the function of EZH2 or c-Myc 
can also be studied. In addition to adipose tissue, this regulatory axis can also be 





Tables and Figures 
Table 1. Macro- and micronutrient composition of the diet in this study 
Diet Formula Control   High Fat 
  gm% kcal%   gm% kcal% 
Protein 19.2 20   24 20 
Carbohydrate 67.3 70   41 35 
Fat 4.3 10   24 45 
Total   100     100 
kcal/gm 3.85     4.73   
           
Ingredient  gm kcal   gm kcal 
Casein, 30 Mesh 200 800   200 800 
L-Cystine 3 12   3 12 
Corn Starch 452.2 1808.8   72.8 291 
Maltodextrin 10 75 300   100 400 
Sucrose 172.8 691.2   172.8 691 
Cellulose, BW200 50 0   50 0 
Soybean Oil 25 225   25 225 
Lard 20 180   177.5 1598 
Mineral Mix S10026 10 0   10 0 
DiCalcium Phosphate 13 0   13 0 




Table 1 (cont.) 
Potassium Citrate, 1 
H2O 
16.5 0   16.5 0 
Vitamin Mix V10001 10 40   10 40 
Choline Bitartrate 2 0   2 0 
FD&C Yellow Dye#5 0.04 0   N/A N/A 
FD&C Red Dye#40 0.01 0   0.05 0 





Table 2. Relative mRNA expression of potential negative transcription factors of miR-
29s in mice from Con and HF group1,2 
 Con HF 
c-Myc 0.50 ± 0.07 1.12 ± 0/11 * 
EZH2 0.94 ± 0.06 1.23 ± 0.11 * 
HDAC3 1.38 ± 0.06 1.00 ± 0.08 * 
NFkB1 0.74 ± 0.05 0.98 ± 0.09 * 
CTNNB1 0.55 ± 0.04 0.60 ± 0.06 
Gli1 1.00 ± 0.11 0.30 ± 0.05 * 
YAP1 1.18 ± 0.05 0.92 ± 0.07 * 
 
1 All values are means ± SEM, n=12 (Con) or 14 (HF). *P<0.05 
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Figure 1. mRNA expression of lipoprotein lipase and hepatic lipase in multiple tissues. 
A) LPL mRNA expression in mouse adipose, muscle and liver. B) HL mRNA expression 





























































































Figure 2. A) Conserved complimentary pairing between miR-29a-3p and LPL 3’UTR. B) 
Conserved complimentary pairing between miR-29b-3p and LPL 3’UTR. C) miR-29a/b 
expression in mouse adipose. All values are means ± SEM, n=12 (Con) or 14 (HF). 




































































































































































































































Figure 3 (cont.) 
and pri-miR-29b2/c regulatory region. S1, S2, S3 and S4 represent Myc-binding site, 
which has E-box sequence. Both pri-miR-29s are highly conserved in their putative 
promoter region on chr.6 (pre-miR-29a/b1) and on chr.1 (pre-miR-29b2/c) respectively. 
B-C) ChIP assay showing c-Myc binding on pri-miR-29a/b1 (B) and pri-miR-29b2/c (C) 
promoters. D-E) ChIP assay showing EZH2 binding on pri-miR-29a/b1 (D) and pri-miR-





[1] Svendsen A. Lipase protein engineering. Biochimica et biophysica acta. 
2000;1543:223-38. 
[2] Wilson RA, Deasy W, Hayes A, Cooke MB. High fat diet and associated changes in 
the expression of micro-RNAs in tissue: Lessons learned from animal studies. Mol Nutr 
Food Res. 2017;61. 
[3] Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. New microRNAs from 
mouse and human. RNA. 2003;9:175-9. 
[4] Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing 
and subcellular localization. Embo j. 2002;21:4663-70. 
[5] Xu P, Vernooy SY, Guo M, Hay BA. The Drosophila MicroRNA Mir-14 Suppresses 
Cell Death and Is Required for Normal Fat Metabolism. Current Biology. 2003;13:790-5. 
[6] Jia LF, Huang YP, Zheng YF, Lyu MY, Wei SB, Meng Z, et al. miR-29b suppresses 
proliferation, migration, and invasion of tongue squamous cell carcinoma through 
PTEN-AKT signaling pathway by targeting Sp1. Oral oncology. 2014;50:1062-71. 
[7] Bouvy-Liivrand M, Heinaniemi M, John E, Schneider JG, Sauter T, Sinkkonen L. 
Combinatorial regulation of lipoprotein lipase by microRNAs during mouse 
adipogenesis. RNA biology. 2014;11:76-91. 
[8] Yang Y, Pan Q, Sun B, Yang R, Fang X, Liu X, et al. miR-29b Targets LPL and TDG 




[9] Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread 
microRNA repression by Myc contributes to tumorigenesis. Nature genetics. 
2008;40:43-50. 
[10] Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, et al. Coordinated silencing of 
MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone 
modification in aggressive B-Cell lymphomas. Cancer cell. 2012;22:506-23. 
[11] Ahn J, Lee H, Chung CH, Ha T. High fat diet induced downregulation of microRNA-
467b increased lipoprotein lipase in hepatic steatosis. Biochem Biophys Res Commun. 
2011;414:664-9. 
[12] Luan Y, Zhang F, Cheng Y, Liu J, Huang R, Yan M, et al. Hemin Improves Insulin 
Sensitivity and Lipid Metabolism in Cultured Hepatocytes and Mice Fed a High-Fat Diet. 
Nutrients. 2017;9. 
[13] Zou Y, Du H, Yin M, Zhang L, Mao L, Xiao N, et al. Effects of high dietary fat and 
cholesterol on expression of PPAR alpha, LXR alpha, and their responsive genes in the 
liver of apoE and LDLR double deficient mice. Mol Cell Biochem. 2009;323:195-205. 
[14] Al-Hasani H, Joost H-G. Nutrition-/diet-induced changes in gene expression in 
white adipose tissue. Best Practice & Research Clinical Endocrinology & Metabolism. 
2005;19:589-603. 
[15] Srivastava RAK, Jahagirdar R, Azhar S, Sharma S, Bisgaier CL. Peroxisome 
proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin 
sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice. Molecular and 
cellular biochemistry. 2006;285:35-50. 
43 
 
[16] Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. Distinct transcriptional 
profiles of adipogenesisin vivo and in vitro. Journal of Biological Chemistry. 
2001;276:34167-74. 
[17] Reynés B, García-Ruiz E, Díaz-Rúa R, Palou A, Oliver P. Reversion to a control 
balanced diet is able to restore body weight and to recover altered metabolic 
parameters in adult rats long-term fed on a cafeteria diet. Food Research International. 
2014;64:839-48. 
[18] Chang CL, Seo T, Matsuzaki M, Worgall TS, Deckelbaum RJ. n-3 Fatty Acids 
Reduce Arterial LDL-Cholesterol Delivery and Arterial Lipoprotein Lipase Levels and 
Lipase Distribution. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:555-
61. 
[19] Seo T, Qi K, Chang C, Liu Y, Worgall TS, Ramakrishnan R, et al. Saturated fat-rich 
diet enhances selective uptake of LDL cholesteryl esters in the arterial wall. The Journal 
of clinical investigation. 2005;115:2214-22. 
[20] Philp LK, Heilbronn LK, Janovska A, Wittert GA. Dietary enrichment with fish oil 
prevents high fat-induced metabolic dysfunction in skeletal muscle in mice. PLoS One. 
2015;10:e0117494. 
[21] Priego T, Sanchez J, Pico C, Palou A. Sex-differential expression of metabolism-
related genes in response to a high-fat diet. Obesity (Silver Spring, Md). 2008;16:819-
26. 




[23] Kim MJ, Kim HK. Perilla leaf extract ameliorates obesity and dyslipidemia induced 
by high-fat diet. Phytotherapy research : PTR. 2009;23:1685-90. 
[24] Boden G, Cheung P, Mozzoli M, Fried SK. Effect of thiazolidinediones on glucose 
and fatty acid metabolism in patients with type 2 diabetes. Metabolism-Clinical and 
Experimental. 2003;52:753-9. 
[25] Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. 
Thiazolidinediones improve β-cell function in type 2 diabetic patients. American Journal 
of Physiology-Endocrinology and Metabolism. 2007;292:E871-E83. 
[26] He W, Barak Y, Hevener A, Olson P, Liao D, Le J, et al. Adipose-specific 
peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat 
and liver but not in muscle. Proceedings of the National Academy of Sciences. 
2003;100:15712-7. 
[27] Jones JR, Barrick C, Kim K-A, Lindner J, Blondeau B, Fujimoto Y, et al. Deletion of 
PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and 
insulin resistance. Proceedings of the National Academy of Sciences. 2005;102:6207-
12. 
[28] Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 
2006;444:881-7. 
[29] Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y, et al. High-fat diet induces significant 




[30] Mastrodonato M, Mentino D, Portincasa P, Calamita G, Liquori GE, Ferri D. High-
fat diet alters the oligosaccharide chains of colon mucins in mice. Histochemistry and 
cell biology. 2014;142:449-59. 
[31] Díaz-Rúa R, García-Ruiz E, Caimari A, Palou A, Oliver P. Sustained exposure to 
diets with an unbalanced macronutrient proportion alters key genes involved in energy 
homeostasis and obesity-related metabolic parameters in rats. Food & function. 
2014;5:3117-31. 
[32] Felipe F, Bonet M, Ribot J, Palou A. Up-regulation of muscle uncoupling protein 3 
gene expression in mice following high fat diet, dietary vitamin A supplementation and 
acute retinoic acid-treatment. International journal of obesity. 2003;27:60. 
[33] Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, et al. A high-fat diet 
coordinately downregulates genes required for mitochondrial oxidative phosphorylation 
in skeletal muscle. Diabetes. 2005;54:1926-33. 
[34] Young SG, Zechner R. Biochemistry and pathophysiology of intravascular and 
intracellular lipolysis. Genes & development. 2013;27:459-84. 
[35] Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, et al. Tissue-specific 
overexpression of lipoprotein lipase causes tissue-specific insulin resistance. 
Proceedings of the National Academy of Sciences. 2001;98:7522-7. 
[36] Li Y, He P-P, Zhang D-W, Zheng X-L, Cayabyab FS, Yin W-D, et al. Lipoprotein 
lipase: From gene to atherosclerosis. Atherosclerosis. 2014;237:597-608. 
[37] Pulinilkunnil T, Rodrigues B. Cardiac lipoprotein lipase: metabolic basis for diabetic 
heart disease. Cardiovascular research. 2006;69:329-40. 
46 
 
[38] Roberts CK, Barnard RJ, Liang KH, Vaziri ND. Effect of diet on adipose tissue and 
skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. 
Atherosclerosis. 2002;161:133-41. 
[39] Davies BS, Beigneux AP, Fong LG, Young SG. New wrinkles in lipoprotein lipase 
biology. Current opinion in lipidology. 2012;23:35. 
[40] Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. American Journal of 
Physiology-Endocrinology and Metabolism. 2009;297:E271-E88. 
[41] Enerbäck S, Gimble JM. Lipoprotein lipase gene expression: physiological 
regulators at the transcriptional and post-transcriptional level. Biochimica et Biophysica 
Acta (BBA)-Lipids and Lipid Metabolism. 1993;1169:107-25. 
[42] Schoonjans K, Peinado‐Onsurbe J, Lefebvre A-M, Heyman RA, Briggs M, Deeb S, 
et al. PPARalpha and PPARgamma activators direct a distinct tissue‐specific 
transcriptional response via a PPRE in the lipoprotein lipase gene. The EMBO journal. 
1996;15:5336-48. 
[43] Haugen BR, Jensen DR, Sharma V, Pulawa LK, Hays WR, Krezel W, et al. 
Retinoid X receptor γ-deficient mice have increased skeletal muscle lipoprotein lipase 
activity and less weight gain when fed a high-fat diet. Endocrinology. 2004;145:3679-85. 
[44] Tengku-Muhammad TS, Cryer A, Ramji DP. Synergism between interferon γ and 
tumour necrosis factor α in the regulation of lipoprotein lipase in the macrophage J774. 
2 cell line. Cytokine. 1998;10:38-48. 
[45] Unal R, Pokrovskaya I, Tripathi P, Monia BP, Kern PA, Ranganathan G. 
Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein 
47 
 
kinase Cα activates binding of the C subunit of protein kinase A to the 3′-untranslated 
region of the lipoprotein lipase mRNA. Biochemical Journal. 2008;413:315-22. 
[46] Irvine SA, Foka P, Rogers SA, Mead JR, Ramji DP. A critical role for the Sp1-
binding sites in the transforming growth factor-β-mediated inhibition of lipoprotein lipase 
gene expression in macrophages. Nucleic acids research. 2005;33:1423-34. 
[47] Yang Y, Pan Q, Sun B, Yang R, Fang X, Liu X, et al. miR-29b Targets LPL and 
TDG Genes and Regulates Apoptosis and Triglyceride Production in MECs. DNA and 
cell biology. 2016;35:758-65. 
[48] Chen T, Li Z, Tu J, Zhu W, Ge J, Zheng X, et al. MicroRNA‐29a regulates pro‐
inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in 
oxLDL‐stimulated dendritic cells. FEBS letters. 2011;585:657-63. 
[49] Tian G-P, Tang Y-Y, He P-P, Lv Y-C, Ouyang X-P, Zhao G-J, et al. The effects of 
miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels 
and atherosclerotic lesions in apolipoprotein E knockout mice. Biochemical and 
biophysical research communications. 2014;443:428-34. 
[50] Zhang M, Wu J-F, Chen W-J, Tang S-L, Mo Z-C, Tang Y-Y, et al. MicroRNA-27a/b 
regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 
macrophages. Atherosclerosis. 2014;234:54-64. 
[51] Bouvy-Liivrand M, Heinäniemi M, John E, Schneider JG, Sauter T, Sinkkonen L. 
Combinatorial regulation of lipoprotein lipase by microRNAs during mouse 
adipogenesis. RNA biology. 2014;11:76-91. 
[52] Dijk W, Kersten S. Regulation of lipoprotein lipase by Angptl4. Trends in 
Endocrinology & Metabolism. 2014;25:146-55. 
48 
 
[53] Zhang R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride 
trafficking. Open biology. 2016;6:150272. 
[54] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 
2004;116:281-97. 
[55] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 
encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-54. 
[56] He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. 
Nature Reviews Genetics. 2004;5:522. 
[57] Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nature reviews 
Molecular cell biology. 2009;10:126-39. 
[58] Lee Y, Jeon K, Lee J-T, Kim S, Kim V. MicroRNA maturation: stepwise processing 
and subcellular localization. The EMBO Journal. 2002;21:4663-70. 
[59] Hutvágner G, McLachlan J, Pasquinelli AE, Bálint É, Tuschl T, Zamore PD. A 
Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the 
<em>let-7</em> Small Temporal RNA. Science. 2001;293:834-8. 
[60] Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, et al. Genes and 
Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal 
RNAs that Control C. elegans Developmental Timing. Cell. 2001;106:23-34. 
[61] Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer 
functions in RNA interference and in synthesis of small RNA involved in developmental 
timing in C. elegans. Genes & development. 2001;15:2654-9. 
[62] Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian 
microRNA host genes and transcription units. Genome research. 2004;14:1902-10. 
49 
 
[63] Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent 
coexpression with neighboring miRNAs and host genes. RNA. 2005;11:241-7. 
[64] Juven-Gershon T, Hsu J-Y, Theisen JWM, Kadonaga JT. The RNA Polymerase II 
Core Promoter – the Gateway to Transcription. Current opinion in cell biology. 
2008;20:253-9. 
[65] Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. 
Features of mammalian microRNA promoters emerge from polymerase II chromatin 
immunoprecipitation data. PLoS One. 2009;4:e5279. 
[66] Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, et al. Chromatin 
structure analyses identify miRNA promoters. Genes & development. 2008;22:3172-83. 
[67] Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y, et al. Structure 
and activity of putative intronic miRNA promoters. RNA. 2010;16:495-505. 
[68] Martinez NJ, Ow MC, Barrasa MI, Hammell M, Sequerra R, Doucette-Stamm L, et 
al. A C. elegans genome-scale microRNA network contains composite feedback motifs 
with high flux capacity. Genes & development. 2008;22:2535-49. 
[69] Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with 
probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858-62. 
[70] Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 
2009;136:215-33. 
[71] Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, et al. MicroRNA-125a-5p partly 
regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-
stimulated monocyte/macrophages. Cardiovascular research. 2009;83:131-9. 
50 
 
[72] Huang R-s, Hu G-q, Lin B, Lin Z-y, Sun C-c. MicroRNA-155 Silencing Enhances 
Inflammatory Response and Lipid Uptake in Oxidized Low-Density Lipoprotein-
Stimulated Human THP-1 Macrophages. Journal of Investigative Medicine. 
2010;58:961-7. 
[73] Xie H, Lim B, Lodish HF. MicroRNAs Induced During Adipogenesis that Accelerate 
Fat Cell Development Are Downregulated in Obesity. Diabetes. 2009;58:1050-7. 
[74] Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. 
MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 
2010;328:1570-3. 
[75] Gharipour M, Sadeghi M. Pivotal role of microRNA-33 in metabolic syndrome: A 
systematic review. ARYA atherosclerosis. 2013;9:372. 
[76] Cioffi M, Vallespinos-Serrano M, Trabulo SM, Fernandez-Marcos PJ, Firment AN, 
Vazquez BN, et al. MiR-93 Controls Adiposity via Inhibition of Sirt7 and Tbx3. Cell 
reports. 2015;12:1594-605. 
[77] Ahn J, Lee H, Jung CH, Ha T. Lycopene inhibits hepatic steatosis via microRNA-
21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet. Mol 
Nutr Food Res. 2012;56:1665-74. 
[78] Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, et al. miR-122, a 
Mammalian Liver-Specific microRNA, is Processed from hcr mRNA and 
MayDownregulate the High Affinity Cationic Amino Acid Transporter CAT-1. RNA 
biology. 2004;1:106-13. 
[79] Gharipour M, Sadeghi M. Pivotal role of microRNA-33 in metabolic syndrome: A 
systematic review. ARYA atherosclerosis. 2013;9:372-6. 
51 
 
[80] Wilson RA, Deasy W, Hayes A, Cooke MB. High fat diet and associated changes in 
the expression of micro‐RNAs in tissue: lessons learned from animal studies. Molecular 
nutrition & food research. 2017. 
[81] Hu ZP, Fang XL, Fang N, Wang XB, Qian HY, Cao Z, et al. Melatonin ameliorates 
vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the 
TLR4/NF-kappaB system in high-fat-fed rabbits. Journal of pineal research. 
2013;55:388-98. 
[82] Zhu HQ, Cheng XW, Xiao LL, Jiang ZK, Zhou Q, Gui SY, et al. Melatonin prevents 
oxidized low-density lipoprotein-induced increase of myosin light chain kinase activation 
and expression in HUVEC through ERK/MAPK signal transduction. Journal of pineal 
research. 2008;45:328-34. 
[83] O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is 
induced during the macrophage inflammatory response. Proceedings of the National 
Academy of Sciences. 2007;104:1604-9. 
[84] Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez-Zapico ME. 
Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and 
NF-kappaB. Journal of cellular biochemistry. 2010;110:1155-64. 
[85] Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M. The miR-29 family: genomics, cell 
biology, and relevance to renal and cardiovascular injury. Physiological genomics. 
2012;44:237-44. 
[86] Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, et al. NF-kappaB-YY1-




[87] Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, et al. TGF-beta/Smad3 
signaling promotes renal fibrosis by inhibiting miR-29. Journal of the American Society 
of Nephrology : JASN. 2011;22:1462-74. 
[88] Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM. miR-29 modulates Wnt 
signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 
2010;285:25221-31. 
[89] Eyholzer M, Schmid S, Wilkens L, Mueller BU, Pabst T. The tumour-suppressive 
miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. British journal of 
cancer. 2010;103:275-84. 
[90] Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, et al. Biological 
functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol 
Chem. 2009;284:15676-84. 
[91] Liu Y, Taylor NE, Lu L, Usa K, Cowley AW, Jr., Ferreri NR, et al. Renal medullary 
microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related 
genes. Hypertension (Dallas, Tex : 1979). 2010;55:974-82. 
[92] Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, et al. 
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs 
encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008;105:5874-8. 
[93] van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et 
al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in 
cardiac fibrosis. Proc Natl Acad Sci U S A. 2008;105:13027-32. 
53 
 
[94] Kurtz CL, Fannin EE, Toth CL, Pearson DS, Vickers KC, Sethupathy P. Inhibition of 
miR-29 has a significant lipid-lowering benefit through suppression of lipogenic 
programs in liver. Sci Rep. 2015;5. 
[95] Caussy C, Charriere S, Meirhaeghe A, Dallongeville J, Lefai E, Rome S, et al. 
Multiple microRNA regulation of lipoprotein lipase gene abolished by 3'UTR 
polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter. 
Atherosclerosis. 2016;246:280-6. 
[96] Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, et al. Progressive miRNA expression 
profiles in cervical carcinogenesis and identification of HPV-related target genes for 
miR-29. The Journal of pathology. 2011;224:484-95. 
[97] Garzon R, Heaphy CEA, Havelange V, Fabbri M, Volinia S, Tsao T, et al. 
MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009;114:5331-41. 
[98] He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 
29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. 
Molecular endocrinology (Baltimore, Md). 2007;21:2785-94. 
[99] Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. 
Oncogene. 2003;22:9007-21. 
[100] Fausto N, Mead JE, Braun L, Thompson NL, Panzica M, Goyette M, et al. Proto-
oncogene expression and growth factors during liver regeneration. Symposium on 
Fundamental Cancer Research. 1986;39:69-86. 
[101] Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, et al. c-Myc 
transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad 
Sci U S A. 1997;94:6658-63. 
54 
 
[102] Kim JW, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O'Donnell KA, et al. Evaluation 
of myc E-box phylogenetic footprints in glycolytic genes by chromatin 
immunoprecipitation assays. Molecular and cellular biology. 2004;24:5923-36. 
[103] Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc 
suppression of miR-23a/b enhances mitochondrial glutaminase expression and 
glutamine metabolism. Nature. 2009;458:762-5. 
[104] Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. 
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis 
and leads to glutamine addiction. Proc Natl Acad Sci U S A. 2008;105:18782-7. 
[105] Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG, et al. 
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma 
cells. Cell cycle (Georgetown, Tex). 2008;7:2392-400. 
[106] Dang CV. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harbor 
perspectives in medicine. 2013;3. 
[107] Loven J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, et al. Revisiting 
global gene expression analysis. Cell. 2012;151:476-82. 
[108] Menendez J, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer 
pathogenesis2007. 
[109] Arlia-Ciommo, Svistkova V, Mohtashami S, Titorenko V. A novel approach to the 
discovery of anti-tumor pharmaceuticals: Searching for activators of liponecrosis2016. 
[110] Morrish F, Hockenbery D. MYC and mitochondrial biogenesis. Cold Spring Harbor 
perspectives in medicine. 2014;4. 
55 
 
[111] Kim J, Lee JH, Iyer VR. Global identification of Myc target genes reveals its direct 
role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One. 2008;3:e1798. 
[112] Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA, et al. Myc 
stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. 
Molecular and cellular biology. 2005;25:6225-34. 
[113] Nishioka C, Ikezoe T, Yang J, Gery S, Koeffler HP, Yokoyama A. Inhibition of 
mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid 
to induce growth arrest and differentiation of human acute myelogenous leukemia cells. 
International journal of cancer. 2009;125:1710-20. 
[114] Zhang C, Yang L, Geng YD, An FL, Xia YZ, Guo C, et al. Icariside II, a natural 
mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-
BP1 axis in sarcoma cells. Oncotarget. 2016;7:27819-37. 
[115] Csibi A, Lee G, Yoon SO, Tong H, Ilter D, Elia I, et al. The mTORC1/S6K1 
pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc 
translation. Current biology : CB. 2014;24:2274-80. 
[116] Shimobayashi M, Hall MN. Making new contacts: the mTOR network in 
metabolism and signalling crosstalk. Nature reviews Molecular cell biology. 
2014;15:155-62. 
[117] Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, 
et al. YAP mediates crosstalk between the Hippo and PI (3) K–TOR pathways by 
suppressing PTEN via miR-29. Nature cell biology. 2012;14:1322. 
[118] Hilton C, Neville M, Karpe F. MicroRNAs in adipose tissue: Their role in 
adipogenesis and obesity2012. 
56 
 
[119] Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation 
and metabolism. The American journal of clinical nutrition. 2006;83:461s-5s. 
[120] Deiuliis J. MicroRNAs as regulators of metabolic disease: Pathophysiologic 
significance and emerging role as biomarkers and therapeutics2015. 
[121] Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annual 
review of physiology. 2010;72:219-46. 
[122] Stinkens R, Goossens GH, Jocken JW, Blaak EE. Targeting fatty acid metabolism 
to improve glucose metabolism. Obesity reviews : an official journal of the International 
Association for the Study of Obesity. 2015;16:715-57. 
[123] Hu ZP, Fang XL, Fang N, Wang XB, Qian HY, Cao Z, et al. Melatonin ameliorates 
vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the 
TLR4/NF‐κB system in high‐fat‐fed rabbits. Journal of pineal research. 2013;55:388-98. 
[124] Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, Yustein JT, et al. Global mapping of 
c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S 
A. 2006;103:17834-9. 
[125] Han H, Sun D, Li W, Shen H, Zhu Y, Li C, et al. A c-Myc-MicroRNA functional 
feedback loop affects hepatocarcinogenesis. Hepatology (Baltimore, Md). 
2013;57:2378-89. 
[126] Chen H, Pan Y-X, Dudenhausen EE, Kilberg MS. Amino acid deprivation induces 
the transcription rate of the human asparagine synthetase gene through a timed 
program of expression and promoter binding of nutrient-responsive basic region/leucine 




[127] Strakovsky RS, Wang H, Engeseth NJ, Flaws JA, Helferich WG, Pan Y-X, et al. 
Developmental bisphenol A (BPA) exposure leads to sex-specific modification of 
hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-
induced hepatic steatosis. Toxicology and applied pharmacology. 2015;284:101-12. 
[128] Walton RG, Zhu B, Unal R, Spencer M, Sunkara M, Morris AJ, et al. Increasing 
adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced 
obesity. Journal of Biological Chemistry. 2015;290:11547-56. 
[129] Yan H, Fei N, Wu G, Zhang C, Zhao L, Zhang M. Regulated Inflammation and 
Lipid Metabolism in Colon mRNA Expressions of Obese Germfree Mice Responding to 
Enterobacter cloacae B29 Combined with the High Fat Diet. Frontiers in microbiology. 
2016;7:1786. 
[130] Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, et al. PPAR-
alpha and PPAR-gamma activators induce cholesterol removal from human 
macrophage foam cells through stimulation of the ABCA1 pathway. Nature medicine. 
2001;7:53-8. 
[131] Pan H, Yang Q, Huang G, Ding C, Cao P, Huang L, et al. Hypolipidemic effects of 
chitosan and its derivatives in hyperlipidemic rats induced by a high-fat diet. Food & 
nutrition research. 2016;60:31137. 
[132] Kobayashi J, Miyashita K, Nakajima K, Mabuchi H. Hepatic Lipase: a 
Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism. Journal 
of atherosclerosis and thrombosis. 2015;22:1001-11. 
[133] Yang P, Subbaiah PV. Regulation of hepatic lipase activity by sphingomyelin in 
plasma lipoproteins. Biochimica et biophysica acta. 2015;1851:1327-36. 
58 
 
[134] Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, et al. A screen in 
mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for 
lipid distribution away from the liver. Hepatology (Baltimore, Md). 2015;61:141-52. 
[135] Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. An integrated database 
of genes responsive to the Myc oncogenic transcription factor: identification of direct 
genomic targets. Genome biology. 2003;4:R69. 
[136] Kim WG, Park JW, Willingham MC, Cheng SY. Diet-induced obesity increases 
tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. 
Endocrinology. 2013;154:2936-47. 
[137] Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, et al. Diet-induced 
obesity elevates colonic TNF-alpha in mice and is accompanied by an activation of Wnt 
signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem. 
2012;23:1207-13. 
[138] Liu S, Kim TH, Franklin DA, Zhang Y. Protection against High-Fat-Diet-Induced 
Obesity in MDM2(C305F) Mice Due to Reduced p53 Activity and Enhanced Energy 
Expenditure. Cell reports. 2017;18:1005-18. 
[139] Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, et al. Histone 
deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic 
lymphocytic leukemia. Blood. 2012;119:1162-72. 
[140] Yoo KH, Hennighausen L. EZH2 methyltransferase and H3K27 methylation in 
breast cancer. International journal of biological sciences. 2012;8:59-65. 
59 
 
[141] Zingg D, Debbache J, Schaefer SM, Tuncer E, Frommel SC, Cheng P, et al. The 
epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing 
of distinct tumour suppressors. Nature communications. 2015;6:6051. 
[142] Li Y, Ren Q, Zhu L, Li Y, Li J, Zhang Y, et al. Involvement of methylation of 
MicroRNA-122, -125b and -106b in regulation of Cyclin G1, CAT-1 and STAT3 target 
genes in isoniazid-induced liver injury. BMC pharmacology & toxicology. 2018;19:11. 
[143] Kohler CU, Bryk O, Meier S, Lang K, Rozynek P, Bruning T, et al. Analyses in 
human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as 
candidate bladder cancer biomarkers. Biochem Biophys Res Commun. 2013;438:48-53. 
[144] Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo M, et al. MicroRNA-10a is down-
regulated by DNA methylation and functions as a tumor suppressor in gastric cancer 
cells. PLoS One. 2014;9:e88057. 
[145] Olivecrona T, Olivecrona G. The ins and outs of adipose tissue.  Cellular lipid 





Appendix A: Supplementary Tables 
Table 3. List of Primers for Real-time Quantitative PCR 
Gene 
Name 
Location Sequence Ensembl/NCBI ID 
LPL mLPL+471F ACCACAGCAGCAAGACCTTC 
ENSMUST00000015
712.14;  
 mLPL+522R GGGCACCCAACTCTCATACA  
HL mHL+698F ATGGCTGGAGGAATCTGC 
ENSMUST00000034
731.9;  
 mHL+761R TCCCAGGCTGTACCCAAT  
CPT1a mCpt1a +160 F CATGAAGCCCTCAAACAGAT 
ENSMUST00000025
835.4  
 mCpt1a +235 R TGCCATTCTTGAATCGGA  
Cpt1b mCpt1b+963F AGAGACAGACTTGCTACAGC 
ENSMUST00000109
313.8;  
 mCpt1b+1039R AGACCTTGAAGAAGCGAC  
C/EBPα mCEBPa+1372F TCGGTGCGTCTAAGATGA 
ENSMUST00000042
985.10;  
 mCEBPa+1433R AAAGTCTCTCGGTCTCAAGG  
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Table 3 (cont.) 
Gli1 mGli1+1054F AATGATGCTTCACCCCCAGT 
ENSMUST00000026
474.4;  
 mGli1+1130R TGCCAACCATCATATCCAGC  
HDAC3 mHDAC3+318F CACCAAGAGCCTTAATGC 
ENSMUST00000043
498.7;  










EZH2 mEZH2+847F GGCACCGCAGAAGAACTG 
ENSMUST00000081
721.12;  
 mEZH2+921R TTCAGGAGGCAGAGCACC  


















CGTGATGGCGTAGAACAGTA   
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Table 3 (cont.) 









GAPDH mGAPDH +149F 




 mGAPDH +234R 
















Table 4. List of Primers for TaqMan MicroRNA Assays 





hsa-miR-29a 002112  4427975 UAGCACCAUCUGAAAUCG
GUUA 
MI0000087 
hsa-miR-29b 000413 4427975 UAGCACCAUUUGAAAUCA
GUGUU 
MI0000105 












Table 5. List of Primers for Chromatin Immunoprecipitation 
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ACCTTGCCCGATAGTTTCCA     
 
 
 
 
